These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21951844

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. A combined approach identifies three mRNAs that are down-regulated by microRNA-29b and promote invasion ability in the breast cancer cell line MCF-7.
    Wang C, Gao C, Zhuang JL, Ding C, Wang Y.
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2127-36. PubMed ID: 22864815
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Relationship between the expression level of miR-29c and biological behavior of gastric cancer].
    Ma XQ, Wang LP, Luo QC, Cai JC.
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):325-30. PubMed ID: 24054006
    [Abstract] [Full Text] [Related]

  • 33. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
    Abdi J, Rastgoo N, Chen Y, Chen GA, Chang H.
    BMC Cancer; 2019 Oct 21; 19(1):975. PubMed ID: 31638931
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S, Zhang Y, Huang C, Lin S.
    J Cell Biochem; 2020 Feb 21; 121(2):1475-1490. PubMed ID: 31498483
    [Abstract] [Full Text] [Related]

  • 37. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX, Xu XX, Tan BZ, Zhang Z, Zhou XD.
    Cell Physiol Biochem; 2017 Feb 21; 41(3):933-946. PubMed ID: 28222438
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon's fibroblasts.
    Li N, Cui J, Duan X, Chen H, Fan F.
    Invest Ophthalmol Vis Sci; 2012 Mar 26; 53(3):1670-8. PubMed ID: 22297492
    [Abstract] [Full Text] [Related]

  • 40. Seliciclib (CYC202, R-Roscovitine) induces cell death in multiple myeloma cells by inhibition of RNA polymerase II-dependent transcription and down-regulation of Mcl-1.
    MacCallum DE, Melville J, Frame S, Watt K, Anderson S, Gianella-Borradori A, Lane DP, Green SR.
    Cancer Res; 2005 Jun 15; 65(12):5399-407. PubMed ID: 15958589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.